elizabetharkema.bsky.social
Principal Researcher & Docent in Epidemiology @ Karolinska Institute |autoimmune disease|epidemiology | statistics | sarcoidosis | lupus
86 posts
1,016 followers
315 following
Regular Contributor
Active Commenter
comment in response to
post
And here’s a place to start bsky.app/profile/ryan...
comment in response to
post
There is congestion pricing here in Stockholm! Seems like a no-brainer.
comment in response to
post
Here is one from Sweden about academic freedom by The Royal Swedish Academy of Sciences
www.kva.se/nyheter/nytt...
comment in response to
post
Karolinska Institutet, in Stockholm Sweden (I am biased since I have worked here for 12 years!) education.ki.se/programme/4f...
comment in response to
post
1) Rice is about to get a lot climate friendlier
Rice cultivation produces around 12% of the world methane gas, which while too unstable to stick around for that long, is 80-100 times more powerful a greenhouse gas than CO2.
A Swedish-Chinese team figured out a fix.
www.cell.com/molecul...
2/24
comment in response to
post
What can you do to help? Re-upping this petition- we are hoping to show legislators very strong support from everywhere! #SaveUSAID 4/END
www.change.org/p/stop-the-u...
comment in response to
post
Oh and now I understand- they get the grant plus overhead and we get the grant then minus the overhead! I didn’t realize that until now.
comment in response to
post
Yeah the sociala avgifter really drive up the costs!
I was thinking we benefit a lot from state subsidized infrastructure - like GWAS is 36 USD a sample through SciLife lab. I applied to a US grant and they thought something was wrong with my budget 😅
comment in response to
post
The NIH only allows 8% overhead for foreign institutions so I had to pay my department to get my NIH funding. 8% hardly covers the effort it takes to do the paperwork for an NIH grant. You have to spend your time applying for more grants to cover the overhead. Hard to actually do the research…
comment in response to
post
Cool that they wrote about it, thanks for sharing!
comment in response to
post
Really nice work @entjos.bsky.social ! 👏
comment in response to
post
Link to thesis: openarchive.ki.se/articles/the...
comment in response to
post
3 studies use nordic registers to study lymphoma survivors. 1 study develops a parametric model for estimating the mean number of events in the presence of competing risks. Implemented the methods study with the R-package JointFPM, which is available on The Comprehensive R Archive Network (CRAN)
comment in response to
post
I wonder how many of the outcomes that are decreased in GLP-1RA-treated patients would also be decreased in people starting any drug that has been newly introduced. Doctors don't prescribe new drugs to people on their deathbed...
comment in response to
post
I would like to replicate these findings and eventually determine which biomarkers could be used in the diagnosis of sarcoidosis. Next is to see which ones (in combination with other measurements, perhaps) are unique to sarcoidosis compared to other diseases in the differential diagnosis.
comment in response to
post
Here is the link to the study: publications.ersnet.org/content/erj/...
comment in response to
post
I am continuing this work to dig in to the causes of sarcoidosis. It is likely that in some patients the disease is initiated or triggered many years before symptoms onset. This means we should look at environmental exposures in an earlier time period.
comment in response to
post
We used Olink's inflammatory panel of 92 proteins to see if any of them were higher than controls before diagnosis. Many of them were, and many were elevated several years before diagnosis (and before symptom onset). There were several we expected - TNF, IFN, and related. But a few that were new.
comment in response to
post
I was thrilled to be able to access population-based data collected in Northern Sweden - an epidemiologist's dream come true. Residents of Västerbotten attended a health check-up and gave blood samples. Thank you!! Also thanks to investigators who initiated & continue this data collection!
comment in response to
post
There is little known about what causes sarcoidosis. Several immune-mediated inflammatory diseases have been shown to have a long pre-clinical period, which can give insight into when the disease actually "begins" but for sarcoidosis this pre-disease period had not been investigated.